Brookfield Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,777
| Closed | -$8.37M | – | 514 |
|
|
2023
Q2 | $8.37M | Buy |
23,777
+22,614
| +1,944% | +$7.96M | 0.03% | 183 |
|
|
2023
Q1 | $366K | Buy |
+1,163
| New | +$366K | ﹤0.01% | 584 |
|
|
2022
Q3 | – | Sell |
-34,445
| Closed | -$9.71M | – | 761 |
|
|
2022
Q2 | $9.71M | Buy |
+34,445
| New | +$9.71M | 0.04% | 150 |
|
|
2022
Q1 | – | Sell |
-42,697
| Closed | -$9.38M | – | 773 |
|
|
2021
Q4 | $9.38M | Buy |
42,697
+29,816
| +231% | +$6.55M | 0.04% | 125 |
|
|
2021
Q3 | $2.34M | Buy |
12,881
+4,039
| +46% | +$732K | 0.01% | 313 |
|
|
2021
Q2 | $1.78M | Buy |
+8,842
| New | +$1.78M | 0.01% | 370 |
|